about
Zaleplon for insomniaZopiclone for insomniaZolpidem for insomniaImplications of circadian rhythm and stress in addiction vulnerabilityInsights into the Role of the Habenular Circadian Clock in AddictionImpact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's DiseaseA narrative review of binge eating and addictive behaviors: shared associations with seasonality and personality factorsRole of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 miceDirect regulation of diurnal Drd3 expression and cocaine reward by NPAS2.Effects of circadian disruption on methamphetamine consumption in methamphetamine-exposed rats.Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior.Time of day influences the voluntary intake and behavioral response to methamphetamine and food reward.Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviourThe clock gene PER2 and sleep problems: association with alcohol consumption among Swedish adolescents.CLOCK is suggested to associate with comorbid alcohol use and depressive disorders.Sleep waves and recovery from drug and alcohol dependence: Towards a rhythm analysis of sleep in residential treatment.Biological substrates of addiction.Persistent gene expression changes in ventral tegmental area of adolescent but not adult rats in response to chronic nicotineCsnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.Assessing ethanol's actions in the suprachiasmatic circadian clock using in vivo and in vitro approaches.Dopaminergic pathway polymorphisms and heroin addiction: further support for association of CSNK1E variants.A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine.Chronic shifts in the length and phase of the light cycle increase intermittent alcohol drinking in C57BL/6J mice.Association Analysis of Nuclear Receptor Rev-erb Alpha Gene (NR1D1) and Japanese Methamphetamine Dependence.Lack of association between prokineticin 2 gene and Japanese methamphetamine dependence.Circadian rhythms, sleep, and substance abuseWhen brain clocks lose track of time: cause or consequence of neuropsychiatric disordersClock genes × stress × reward interactions in alcohol and substance use disordersThe longitudinal course of sleep timing and circadian preferences in adults with bipolar disorderExperimental psychiatric illness and drug abuse models: from human to animal, an overviewA promoter polymorphism in the Per3 gene is associated with alcohol and stress response.Sleep and gambling severity in a community sample of gamblersFunctional mapping of the neuronal substrates for drug tolerance in DrosophilaGenetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.Genetic deletion of MT(1) and MT(2) melatonin receptors differentially abrogates the development and expression of methamphetamine-induced locomotor sensitization during the day and the night in C3H/HeN miceCocaine self-administration behaviors in ClockΔ19 miceThe circadian Per1 and Per2 genes influence alcohol intake, reinforcement, and blood alcohol levels.Animal care practices in experiments on biological rhythms and sleep: report of the Joint Task Force of the Society for Research on Biological Rhythms and the Sleep Research Society.Cognitive dysfunction, elevated anxiety, and reduced cocaine response in circadian clock-deficient cryptochrome knockout miceAddiction and the adrenal cortex
P2860
Q24200706-4A34C762-2A0E-48EA-9D07-AF1888411C85Q24200717-A6AD1A12-9769-4397-8FB9-CD9EEC2A5471Q24200727-93BB84E1-F5AD-41F8-A00B-07E1019F2496Q26766394-DB0253A0-6F7B-403B-A05C-E8D83BF8AA2BQ26771502-6844E46E-B123-47AD-9716-73BC3E3CAE1DQ26776152-F4F31C2C-EDAA-43DE-A60F-F51B4F62485BQ27022115-B3D1C216-EE55-4F25-8F80-A935D13D6DFBQ27325422-00795A51-4305-494E-90BF-CC7DCD118C0AQ27329016-5DBD2948-4A88-44D8-A757-1F01360CAC7FQ30301057-702EBE01-1494-4EB8-A11D-7E45C7260317Q30541494-35FC053E-937F-41A9-A9BB-3679B7771FA1Q30653659-7DE0F91C-6D7E-4109-A725-CD347E9513BBQ30657215-9CBD56FF-DF69-4F0E-8A99-59BFB1B8E423Q33784169-097D7A0D-A826-4118-9046-88E5C17A5054Q33787302-4E1BD33E-312D-4315-92B1-221FA24E94FDQ33788223-E4C1D6CD-5746-46A8-ABAF-B64CDD501E0AQ33835356-1948A4BD-987C-42A9-8A3D-BC28AE8D9130Q34232590-6BEA5EB0-60AD-4B84-BB4A-C9BECE200B20Q34233183-805A9444-D188-4193-BA5F-D71396533E1FQ34451242-361764B9-ADA8-4628-AE92-E29459611664Q34891066-95B2C4B3-8CEC-4007-BD3B-35441435D4B5Q34892958-DF3C874C-23DE-4DC4-BE9E-AA3225FC44F7Q35042203-93BF9294-2D16-4ACC-B0C1-556EAB551794Q35107751-29A3CB9A-F20D-42FE-A083-162B276E983FQ35107755-1946E876-57F2-48C4-87B4-9D944D4FFE9CQ35223885-DBA3022B-2C84-490C-9DAE-06D773E9C482Q35655918-757F18F1-5452-4924-B994-BAFF4622617BQ35688786-13187695-E9E7-4FD9-AB72-C0D6744E6059Q35690336-E32E4DB9-BC5F-43A3-B7D8-1DF1112914DEQ35774481-EFC3790E-5D14-4823-9B07-F959A7F281C5Q35844303-453FA2ED-6DFF-440E-AC00-D5CFA44FB0AEQ35890882-E05E2D59-F9B7-47A7-A6C2-75E290C1E16EQ36100573-4422E8CC-174D-4784-BE9C-BFEB26DD8F1DQ36423565-0015F7C5-7B7B-43FB-9F5F-0FA72A7F9279Q36598788-DEEE167D-FC33-4D17-9EEF-0D7808FE4D8BQ36895169-C8C40965-1421-41E6-AF97-9FFF7CF0B1E4Q36901866-BB7309E1-A013-4BBD-891E-8F5335DA92B1Q37052231-C7786703-FD0F-4C9E-805F-98264028B16AQ37253349-B1071ADE-D5AE-4BAF-82A5-C26BAB5B44B0Q37354295-018398A3-1212-4241-89ED-70A727500A36
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A role for the circadian genes in drug addiction.
@en
A role for the circadian genes in drug addiction.
@nl
type
label
A role for the circadian genes in drug addiction.
@en
A role for the circadian genes in drug addiction.
@nl
prefLabel
A role for the circadian genes in drug addiction.
@en
A role for the circadian genes in drug addiction.
@nl
P2860
P1433
P1476
A role for the circadian genes in drug addiction.
@en
P2093
Colleen A McClung
Edgardo Falcón
P2860
P356
10.1016/J.NEUROPHARM.2008.06.054
P478
56 Suppl 1
P577
2008-07-03T00:00:00Z